DK0633886T3 - Farmaceutisk aktive bicyclisk-heterocycliske aminer - Google Patents

Farmaceutisk aktive bicyclisk-heterocycliske aminer

Info

Publication number
DK0633886T3
DK0633886T3 DK93908303T DK93908303T DK0633886T3 DK 0633886 T3 DK0633886 T3 DK 0633886T3 DK 93908303 T DK93908303 T DK 93908303T DK 93908303 T DK93908303 T DK 93908303T DK 0633886 T3 DK0633886 T3 DK 0633886T3
Authority
DK
Denmark
Prior art keywords
pharmaceutically active
heterocyclic amines
active bicyclic
bicyclic
xxx
Prior art date
Application number
DK93908303T
Other languages
English (en)
Inventor
Gordon L Bundy
Eric Jon Jacobsen
Donald E Ayer
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK0633886T3 publication Critical patent/DK0633886T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26Acyclic or carbocyclic radicals, substituted by hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK93908303T 1992-04-03 1993-03-16 Farmaceutisk aktive bicyclisk-heterocycliske aminer DK0633886T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86364692A 1992-04-03 1992-04-03
PCT/US1993/002188 WO1993020078A1 (en) 1992-04-03 1993-03-16 Pharmaceutically active bicyclic-heterocyclic amines

Publications (1)

Publication Number Publication Date
DK0633886T3 true DK0633886T3 (da) 2000-12-18

Family

ID=25341481

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93908303T DK0633886T3 (da) 1992-04-03 1993-03-16 Farmaceutisk aktive bicyclisk-heterocycliske aminer

Country Status (21)

Country Link
EP (1) EP0633886B1 (da)
JP (1) JPH08502721A (da)
KR (1) KR100284473B1 (da)
AT (1) ATE197051T1 (da)
AU (1) AU675932B2 (da)
CA (1) CA2130937A1 (da)
CZ (1) CZ236494A3 (da)
DE (1) DE69329574T2 (da)
DK (1) DK0633886T3 (da)
ES (1) ES2150941T3 (da)
FI (1) FI944602A (da)
GR (1) GR3035188T3 (da)
HU (1) HUT70954A (da)
LV (1) LV12794B (da)
MX (1) MX9301847A (da)
NO (1) NO303542B1 (da)
PL (2) PL175327B1 (da)
PT (1) PT633886E (da)
RU (1) RU2103272C1 (da)
SK (1) SK119194A3 (da)
WO (1) WO1993020078A1 (da)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ304519A (en) * 1995-03-02 2000-01-28 Upjohn Co Pydrimido[4,5-b]indoles
PT948495E (pt) 1996-11-19 2004-08-31 Amgen Inc Agentes anti-inflamatorios de pirrolo fundido substituidos em arilo e heteroarilo
WO1998024453A1 (fr) * 1996-12-05 1998-06-11 Nippon Shinyaku Co., Ltd. Medicaments pour la myelopathie
DE69719563T2 (de) * 1997-01-08 2003-11-27 Pharmacia & Upjohn Co., Kalamazoo Pharmazeutische wirksame trizyklische amine
GB9716657D0 (en) 1997-08-07 1997-10-15 Zeneca Ltd Chemical compounds
GB2331988B (en) 1997-12-04 2003-04-16 Imperial College Polycyclic sulphamate inhibitors or oestrone sulphatase
GB9803226D0 (en) 1998-02-17 1998-04-08 Zeneca Ltd Chemical compounds
BR9911612A (pt) * 1998-06-02 2001-02-06 Osi Pharm Inc Composições de pirrolo[2,3d]pirimidina e seus usos
US6686366B1 (en) 1998-06-02 2004-02-03 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6878716B1 (en) 1998-06-02 2005-04-12 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptor and uses thereof
PA8474101A1 (es) * 1998-06-19 2000-09-29 Pfizer Prod Inc Compuestos de pirrolo [2,3-d] pirimidina
JP2003524598A (ja) * 1998-09-04 2003-08-19 アルタナ ファルマ アクチエンゲゼルシャフト 新規ピラノセン
GB9902461D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902453D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902459D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902452D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9902455D0 (en) 1999-02-05 1999-03-24 Zeneca Ltd Chemical compounds
GB9918035D0 (en) 1999-07-30 1999-09-29 Novartis Ag Organic compounds
US7160890B2 (en) 1999-12-02 2007-01-09 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680322B2 (en) 1999-12-02 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
EP1731520A1 (en) * 1999-12-02 2006-12-13 OSI Pharmaceuticals, Inc. Pyrrolo[2,3-d]pyrimidine derivatives which are antagonists of adenosine A1, A2A, and A3
US6664252B2 (en) 1999-12-02 2003-12-16 Osi Pharmaceuticals, Inc. 4-aminopyrrolo[2,3-d]pyrimidine compounds specific to adenosine A2a receptor and uses thereof
DE60021423T2 (de) 1999-12-21 2006-04-13 Sugen, Inc., San Diego 4-substituierte 7-aza-indolin-2-one und ihre verwendung als proteinkinaseinhibitoren
GB0000625D0 (en) 2000-01-13 2000-03-01 Zeneca Ltd Chemical compounds
EP1254115A2 (en) 2000-02-11 2002-11-06 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases
US20020061897A1 (en) 2000-03-30 2002-05-23 Elliott Richard L. Neuropeptide Y antagonists
ATE362468T1 (de) 2000-07-25 2007-06-15 Merck & Co Inc N-substituierte indole mit anwendung in der behandlung von diabetes
SE0003795D0 (sv) 2000-10-20 2000-10-20 Astrazeneca Ab Pharmaceutically useful compounds
US6673802B2 (en) 2000-12-01 2004-01-06 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A3 receptor and uses thereof
US6680324B2 (en) 2000-12-01 2004-01-20 Osi Pharmaceuticals, Inc. Compounds specific to adenosine A1 receptors and uses thereof
GB0100622D0 (en) 2001-01-10 2001-02-21 Vernalis Res Ltd Chemical compounds V111
GB0117396D0 (en) 2001-07-17 2001-09-05 Glaxo Group Ltd Chemical compounds
WO2003048120A2 (en) 2001-11-30 2003-06-12 Osi Pharmaceuticals, Inc. 2-aryl pyrrologpyrimidines for a1 and a3 receptors
BR0215202A (pt) 2001-12-20 2004-10-13 Osi Pharm Inc Compostos antagonistas seletivos a2b de pirimidina, sua sìntese e uso
CN101973998A (zh) 2001-12-20 2011-02-16 Osi药物公司 吡咯并嘧啶A2b选择性拮抗剂化合物
US7285550B2 (en) 2003-04-09 2007-10-23 Biogen Idec Ma Inc. Triazolotriazines and pyrazolotriazines and methods of making and using the same
GB0308208D0 (en) 2003-04-09 2003-05-14 Glaxo Group Ltd Chemical compounds
US7834014B2 (en) 2003-04-09 2010-11-16 Biogen Idec Ma Inc. A2a adenosine receptor antagonists
EP1615931A1 (en) 2003-04-09 2006-01-18 Biogen Idec MA Inc. Triazolopyrazines and methods of making and using the same
CA2551567C (en) * 2003-12-23 2014-04-29 Abraxis Bioscience, Inc. Propofol analogs, process for their preparation, and methods of use
JP5078350B2 (ja) * 2004-03-04 2012-11-21 キッセイ薬品工業株式会社 縮合ヘテロ環誘導体、それを含有する医薬組成物およびその医薬用途
MXPA06014798A (es) 2004-06-17 2007-06-22 Wyeth Corp Antagonistas del receptor de hormona para liberar gonadotropina.
AU2005264998A1 (en) 2004-06-17 2006-01-26 Wyeth The present invention relates to methods of making Gonadotropin Releasing Hormone ('GnRH') (also known as Leutinizing Hormone Releasing Hormone) receptor antagonists
RU2007101705A (ru) 2004-06-18 2008-07-27 Биолипокс Аб (Se) Индолы, полезные для лечения воспаления
FR2880626B1 (fr) * 2005-01-13 2008-04-18 Aventis Pharma Sa Derives de la purine, compositions les contenant et utilisation
KR20070114123A (ko) 2005-01-19 2007-11-29 바이올리폭스 에이비 염증 치료에 유용한 인돌
US7534796B2 (en) 2005-02-18 2009-05-19 Wyeth Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor
US7582634B2 (en) 2005-02-18 2009-09-01 Wyeth 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
US7538113B2 (en) 2005-02-18 2009-05-26 Wyeth 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor
FR2884824B1 (fr) 2005-04-20 2007-07-13 Sanofi Aventis Sa Derives de 1h-pyrimido[4,5-b]indole, leur preparation et leur application en therapeutique
US7531542B2 (en) 2005-05-18 2009-05-12 Wyeth Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor
US7582636B2 (en) 2005-05-26 2009-09-01 Wyeth Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor
UA95788C2 (en) 2005-12-15 2011-09-12 Ф. Хоффманн-Ля Рош Аг Fused pyrrole derivatives
KR100749216B1 (ko) * 2006-08-30 2007-08-13 위아 주식회사 4륜구동차량용 부변속기
WO2008055808A1 (en) 2006-11-09 2008-05-15 F. Hoffmann-La Roche Ag Indole and benzofuran 2-carboxamide derivatives
WO2009020990A1 (en) * 2007-08-08 2009-02-12 Smithkline Beecham Corporation 2- [ (2-{phenylamino}-1h-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as igf-1r inhibitors for the treatment of cancer
BRPI0814958B8 (pt) * 2007-08-17 2021-05-25 Lg Chemical Ltd compostos de indol, e, composição
AR070127A1 (es) 2008-01-11 2010-03-17 Novartis Ag Pirrolo - pirimidinas y pirrolo -piridinas
PT2240482E (pt) 2008-01-31 2013-09-06 Sanofi Sa Azaindole-3-carboxamidas cíclicas, sua preparação e sua utilização como fármacos
TW200938201A (en) * 2008-02-07 2009-09-16 Chugai Pharmaceutical Co Ltd Pyrrolopyrimidine derivative as PI3K inhibitor and use thereof
KR20110098908A (ko) * 2008-11-11 2011-09-02 엑스커버리 홀딩 컴퍼니 엘엘씨 PI3K/mTOR 키나제 억제제
EP2624696B1 (en) 2010-10-06 2016-12-21 Glaxosmithkline LLC Benzimidazole derivatives as pi3 kinase inhibitors
PE20140293A1 (es) * 2011-01-31 2014-03-19 Novartis Ag Novedosos derivados heterociclicos
BR112013023266B8 (pt) 2011-03-15 2021-04-06 L Livermore Nat Security Llc inibidores da girase tricíclicos
CA2853256C (en) 2011-10-28 2019-05-14 Novartis Ag Novel purine derivatives and their use in the treatment of disease
DK2807165T3 (da) 2012-01-27 2019-07-15 Univ Montreal Pyrimido[4,5-b]indol-derivater og anvendelse deraf i ekspansionen af hæmatopoietiske stamceller
CN105732639A (zh) 2012-06-29 2016-07-06 辉瑞大药厂 作为LRRK2抑制剂的4-(取代的氨基)-7H-吡咯并〔2,3-d〕嘧啶类
ES2663622T3 (es) 2013-12-17 2018-04-16 Pfizer Inc. Novedosas 1H-pirrolo[2,3-b]piridinas 3,4-disustituidas y 7H-pirrolo[2,3-c]piridacinas 4,5-disustituidas como inhibidores de LRRK2
CN106414446A (zh) * 2014-03-13 2017-02-15 新加坡科技研究局 基于稠合嘧啶的异羟肟酸盐衍生物
AU2015321654B2 (en) * 2014-09-22 2019-10-31 National Health Research Institutes Heterocyclic compounds and use thereof
KR102278306B1 (ko) 2015-06-05 2021-07-15 헤마-퀘벡 조혈 줄기세포를 전구 세포로 배양 및/또는 분화시키는 방법 및 그의 용도
RU2722149C1 (ru) 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2
US9630968B1 (en) 2015-12-23 2017-04-25 Arqule, Inc. Tetrahydropyranyl amino-pyrrolopyrimidinone and methods of use thereof
TW201811795A (zh) 2016-08-24 2018-04-01 美商亞闊股份有限公司 胺基-吡咯并嘧啶酮化合物及其用途
TW201815787A (zh) 2016-09-23 2018-05-01 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201813963A (zh) 2016-09-23 2018-04-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
TW201825465A (zh) 2016-09-23 2018-07-16 美商基利科學股份有限公司 磷脂醯肌醇3-激酶抑制劑
RU2020129785A (ru) * 2018-02-16 2022-03-16 Юсб Байофарма Срл Фармацевтические производные 6,5-гетеробициклического кольца
US20240150358A1 (en) * 2020-06-03 2024-05-09 Kineta, Inc. Purines and methods of their use
US20230234943A1 (en) * 2020-06-26 2023-07-27 Tempest Therapeutics, Inc. Trex1 inhibitors and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB864145A (en) * 1959-06-02 1961-03-29 Thomae Gmbh Dr K Novel purines and a process for their manufacture
GB1268772A (en) * 1968-03-15 1972-03-29 Glaxo Lab Ltd NOVEL alpha-CARBOLINE DERIVATIVES, THE PREPARATION THEREOF AND COMPOSITIONS CONTAINING THE SAME
KR970009225B1 (ko) * 1989-09-19 1997-06-09 데이진 가부시끼가이샤 피롤로[2,3-디] 피리미딘 유도체, 그의 제조방법 및 그것을 유효성분으로 하는 의약제제

Also Published As

Publication number Publication date
WO1993020078A1 (en) 1993-10-14
AU675932B2 (en) 1997-02-27
PL175347B1 (pl) 1998-12-31
MX9301847A (es) 1993-10-01
NO943655D0 (no) 1994-09-30
DE69329574D1 (de) 2000-11-23
DE69329574T2 (de) 2001-05-31
EP0633886B1 (en) 2000-10-18
FI944602A0 (fi) 1994-10-03
CZ236494A3 (en) 1994-12-15
ES2150941T3 (es) 2000-12-16
EP0633886A1 (en) 1995-01-18
NO303542B1 (no) 1998-07-27
KR100284473B1 (ko) 2001-04-02
PL175327B1 (pl) 1998-12-31
LV12794B (en) 2002-06-20
KR950700912A (ko) 1995-02-20
RU2103272C1 (ru) 1998-01-27
CA2130937A1 (en) 1993-10-14
GR3035188T3 (en) 2001-04-30
NO943655L (no) 1994-12-05
SK119194A3 (en) 1995-05-10
HU9402829D0 (en) 1995-02-28
AU3917493A (en) 1993-11-08
PT633886E (pt) 2001-03-30
FI944602A (fi) 1994-10-03
HUT70954A (en) 1995-11-28
JPH08502721A (ja) 1996-03-26
LV12794A (en) 2002-02-20
ATE197051T1 (de) 2000-11-15
RU94042466A (ru) 1996-07-20

Similar Documents

Publication Publication Date Title
DK0633886T3 (da) Farmaceutisk aktive bicyclisk-heterocycliske aminer
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
BR0112756A (pt) Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto
ATE119520T1 (de) Derivate von hydroxaminsäure und von n- hydroxyharnstoff sowie ihre verwendung.
BR9807673A (pt) Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica.
BR9806157A (pt) Composições farmacêuticas de descarboetoxiloratadina anidras, não higroscópicas e sem lactose
PT705100E (pt) Guanidinas substituidas terapeuticas
CA2198706A1 (en) Methods for the treatment of inflammatory joint disease
EP0260305A4 (en) CHINOLINYL ETHER TETRAZOLE AS A MEDIUM FOR TREATING HYPER-SENSITIVE DISEASES.
BR9903737A (pt) Carbamatos em c-11 de macrólidos antibacterianos
DK1032556T3 (da) Farmaceutisk aktive forbindelser og anvendelsesfremgangsmåder
HK1067298A1 (zh) 應用於治療皮膚和/或粘膜損傷的體表應用的藥物組合物;組合物在治療皮膚和/或粘膜損傷中的用途和化合物在治療皮膚和/或粘膜損傷中的用途
SE9900833D0 (sv) Novel combination
BR0115883A (pt) Derivados de ácido amino-furan-2-il-acético e ácido amino-tien-2-il-acético substituìdos e seu emprego para o tratamento de cefaléia ou dor
CA2427814A1 (en) A combination of a pde4 inhibitor and a leukotriene antagonist in the treatment of bronchial and respiratory disorders
SE9900834D0 (sv) Novel combination
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
MY130725A (en) Composition and method for treating allergic diseases
PT882038E (pt) N-metil-n-(4-(piperidin-1-il)-2-(aril)butil)benzamidas substituidas vantajosas para o tratamento de doencas alergicas
CA2404210A1 (en) Pharmaceutical gel composition
SE8402199L (sv) Farmaceutiskt preparat innehallande co-dergocrin och en kalciumantagonist
BR9507732A (pt) Composição farmacêutica para o tratamento de glaucoma
HUP9900401A3 (en) Novel substituted n-methyl-n-(4-(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases, pharmaceutical compositions containing them and their use
RU95102777A (ru) Способ лечения реперфузного повреждения и "оглушения" миокарда